CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project investigates the progression and treatment resistance of Multiple Myeloma, utilizing omics technologies and bioinformatics. It aims to identify biological pathways and risk factors, facilitating personalized approaches to diagnosis and therapy.
Multiple Myeloma is a chronic malignancy characterized by slow progression and recurrences.
Currently there is no effective cure since eventually the disease develops resistance to all the available therapeutic approaches.
Although recent advances have expanded our understanding of the cellular functions associated with health to disease transition, recurrence and response to therapy, critical aspects of this complex pathology remain to be elucidated.
Application of omics technologies, and bioin…
ETHNIKO KAI KAPODISTRIAKO PANEPISTIMIO ATHINON
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
BIOMEDICAL RESEARCH FOUNDATION, ACADEMY OF ATHENS
Greece, Athina
Type: Research institute
Activity type: Research Organisations
SME: No
NATIONAL HELLENIC RESEARCH FOUNDATION EIE NHRF
Greece, Athina
Type: Research institute
Activity type: Research Organisations
SME: No
Italy, Torino
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Spain, Pamplona
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 sectors.
Guests see up to 5 keywords.
